1 / 80

Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach

Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach. Process. A Patient-Centered Approach. Approach to Management of Hyperglycemia. ADA/EASD Position Statement on Therapeutic Options: Lifestyle. Metformin. 2-Drug Combinations. 3-Drug Combinations.

Download Presentation

Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach

  2. Process

  3. A Patient-Centered Approach

  4. Approach to Management of Hyperglycemia

  5. ADA/EASD Position Statement on Therapeutic Options: Lifestyle

  6. Metformin

  7. 2-Drug Combinations

  8. 3-Drug Combinations

  9. More Complex Insulin Strategies

  10. Other Treatment Considerations

  11. Choice of Antihyperglycemic Agent

  12. What Is New?

  13. Some Issues

  14. Thank you for participatingin this activity.

  15. Considerations for Treating the Patient With Newly Diagnosed Type 2 Diabetes

  16. Patient Case

  17. Our First Goal Is to Set Appropriate HbA1c

  18. Therapeutic Choices in T2D Should Be Patient -Centered and Agent-Specific

  19. 2012 ADA/EASD Position Statement

  20. Therapeutic Strategies to Avoid Hypoglycemia and Weight Gain and Minimize Costs

  21. Thank you for participatingin this activity.

  22. Management of a Patient With Longstanding Type 2 Diabetes

  23. Patient Case

  24. 2012 ADA/EASD Position Statement

  25. Combined Effects of Metformin With Insulin Therapy in T2D*

  26. Metaanalysis: Effectiveness of Basal Insulin in Achieving HbA1c < 7%

  27. Postprandial Hyperglycemia Persists After Basal Therapy

  28. Basal Bolus Insulin: Percent of Patients With HbA1c > 7%

  29. Optimizing Insulin Therapy When Basal Insulin Is Not Enough

  30. Exenatide BID Added to Glargine

  31. Saxagliptin Improves Glycemic Control With Low Rates of Hypoglycemia >24 Wks in T2D

  32. Optimizing Insulin Therapy When Basal Insulin Is Not Enough

  33. Thank you for participatingin this activity.

  34. Initiating and Intensifying Insulin Therapy in Type 2 Diabetes

  35. Case Report

  36. 2012 ADA/EASD Position Statement

  37. Progressive Hyperglycemia Despite Insulin, Sulfonylurea, or Metformin

  38. Patient Case Recommendations

  39. Currently Available Insulins

  40. Treat-to-Target Study

  41. Exenatide vs Glargine Added to Oral Agents

  42. GLP-1 Receptor Agonists: Effects on Cardiovascular Risk Factors

  43. Case Recap and Questions

  44. Thank you for participatingin this activity.

  45. Management of Type 2 Diabetes in Patients With CKD

  46. Case Report

  47. 2012 ADA/EASD Position Statement

More Related